This CE activity will allow providers caring for the BMT patient population more opportunity for transplant specific education which will in turn help those providers meet the 10 education hours as defined by FACT Standard B3.5.3. This free, on campus lecture series makes regular attendance more obtainable and affordable for participants while providing transplant specific education that promotes quality patient centered care.
Key Words: CAR-T, Transplant, Multiple Myeloma
- Physician Assistant
Participants who engage in this educational intervention will be able to:
- Describe updates in management of CRS and ICANS after CAR-T cell therapy
- Define IEC-HS
- Describe significance of IEC-HS after CAR T-cell therapy
Presenter:
Activity Directors:
Valerie Ehrlich, PA-C
Department of Medicine
Division of Hematology and Oncology
Medical College of Wisconsin-Froedtert
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Valerie Ehrlich
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
Name | Company | Role |
---|---|---|
Nirav Shah | LOXO-Lilly, Miltenyi Biotech | Consultant/Researcher |
Epizyme | Advisory Committee |
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.